Clinical pipeline

Galapagos is progressing one of the largest pipelines in biotech, with five Phase 2 programs (two exclusively licensed to GSK), one Phase 1 program, and more than 20 discovery programs.

Share to Facebook Share to Twitter Share to LinkedIn Share via Email

© Copyright 2013 Galapagos NV | Disclaimer | General Purchase Terms 

 
Test